Dolutegravir Package Insert Food

facebook share image   twitter share image   pinterest share image   E-Mail share image

More about "dolutegravir package insert food"

HIGHLIGHTS OF PRESCRIBING INFORMATION DOLUTEGRAVIR …
Web Dolutegravir may be considered during the second and third trimesters of pregnancy if the expected benefit justifies the potential risk to the pregnant woman and the fetus. 5.4 Risk …
From accessdata.fda.gov
File Size 437KB
Page Count 42


HIGHLIGHTS OF PRESCRIBING INFORMATION DOVATO. VARIANTS …
Web DOVATO is a fixed-dose combination product containing 50 mg of dolutegravir and 300 mg of lamivudine. The recommended dosage regimen of DOVATO in adults is one tablet …
From accessdata.fda.gov
File Size 446KB
Page Count 38


HIGHLIGHTS OF PRESCRIBING INFORMATION REPORTED WITH …
Web DOVATO is a fixed-dose combination product containing 50 mg of dolutegravir and 300 mg of lamivudine. The recommended dosage regimen of DOVATO in adults is one tablet …
From gskpro.com
File Size 634KB
Page Count 38


HIGHLIGHTS OF PRESCRIBING INFORMATION - FOOD AND DRUG …
Web a Rilpivirine dose is 25 mg once daily for those switching to dolutegravir plus rilpivirine. b Alternative combinations that do not include metabolic inducers should be considered …
From accessdata.fda.gov
File Size 1005KB
Page Count 44


DOLUTEGRAVIR / LAMIVUDINE - PATIENT | NIH - HIV.GOV
Web Apr 10, 2023 Dovato is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults who meet certain …
From clinicalinfo.hiv.gov


DOLUTEGRAVIR (TIVICAY) PACKAGE INSERT | DAIDS REGULATORY SUPPORT …
Web Apr 6, 2023 Dolutegravir (Tivicay) Package Insert TIVICAY is a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI) indicated in combination …
From rsc.niaid.nih.gov


DOLUTEGRAVIR - PATIENT | NIH - HIV.GOV
Web The Patient Package Insert includes information for people taking dolutegravir. The American Hospital Formulary Service (AHFS) Patient Medication Information for …
From clinicalinfo.hiv.gov


DOLUTEGRAVIR - TABLET (FILM COATED), TABLET (FOR SUSPENSION) | NIH
Web FDA label information. Several FDA-approved drug labels may be available for dolutegravir. Clinicalinfo provides the following link to the DailyMed drug label solely as …
From clinicalinfo.hiv.gov


TIVICAY | EUROPEAN MEDICINES AGENCY
Web Mar 7, 2023 Tivicay is a medicine used together with other medicines to treat adults and children from 4 weeks of age and weighing at least 3 kg who are infected with human …
From ema.europa.eu


DOLUTEGRAVIR: MEDLINEPLUS DRUG INFORMATION
Web Dolutegravir is used with other medications to treat human immunodeficiency virus (HIV) infection in adults and children 4 weeks of age and older who weigh at least 6.6 lbs (3 …
From medlineplus.gov


HIGHLIGHTS OF PRESCRIBING INFORMATION
Web with documented or clinically suspected resistance to other INSTIs (raltegravir, elvitegravir). Reference ID: 3356149 3 29 3 DOSAGE FORMS AND STRENGTHS 30 …
From accessdata.fda.gov


ANTIRETROVIRAL MEDICATION DOLUTEGRAVIR (DTG, TIVICAY, TIVICAY PD ...
Web Metabolism: Dolutegravir (DTG) is a uridine diphosphate glucuronyl transferase (UGT) 1A and cytochrome P450 (CYP) 3A substrate and may require dose adjustments when …
From clinicalinfo.hiv.gov


HIGHLIGHTS OF PRESCRIBING INFORMATION • TIVICAY PD …
Web TIVICAY tablets may be taken with or without food. 3 Table 1. Dosing Recommendations for TIVICAY Tablets in Adult Patients Population Recommended Dosage Treatment-naïve …
From gskpro.com


HIGHLIGHTS OF PRESCRIBING INFORMATION - FOOD AND DRUG …
Web ABC = abacavir, DTG = dolutegravir , 3TC = lamivudine. • Do not interchange TRIUMEQ and TRIUMEQ PD on a milligram-per-milligram basis. (2. 3) • If dosing with certain …
From accessdata.fda.gov


DOLUTEGRAVIR (MYLAN LABORATORIES LIMITED): FDA PACKAGE INSERT
Web Mar 5, 2021 Mylan Laboratories Limited: Dolutegravir Tablets for Oral Suspension 10 mg Bottle Label. Dolutegravir. Mylan Laboratories Limited 5 March 2021. DOLUTEGRAVIR …
From medlibrary.org


DOLUTEGRAVIR (ORAL ROUTE) PROPER USE - MAYO CLINIC
Web Apr 1, 2023 This medicine comes with a patient information insert. Read and follow the instructions carefully. ... Do not use any other drink or food. ... If you are switching to …
From mayoclinic.org


HIGHLIGHTS OF PRESCRIBING INFORMATION DOLUTEGRAVIR PLUS …
Web Dolutegravir tablets may be taken with or without food. Table 1. Dosing Recommendations for Dolutegravir tablets in Adult Patients Population Recommended Dosage Treatment …
From accessdata.fda.gov


DOLUTEGRAVIR, A SECOND-GENERATION INTEGRASE INHIBITOR FOR THE …
Web Dolutegravir is the first second-generation INSTI and exhibits several advantages over current integrase inhibitors and other preferred antiretrovirals. Long-term efficacy and …
From pubmed.ncbi.nlm.nih.gov


DOLUTEGRAVIR (TIVICAY) PI DATED OCTOBER 2019
Web 25 mg: Each tablet contains 25 mg of dolutegravir (as dolutegravir sodium). Tablets are pale yellow, round, film-coated, biconvex tablets debossed with “SV 572” on one side …
From rsc.niaid.nih.gov


ENTERAL ADMINISTRATION OF TWICE-DAILY - SAGE JOURNALS
Web food, although increases in the area under the concentration time curve and maximum concentration of 66% and 67%, result, respectively, when administered with a high-fat ... Tivicay (dolutegravir) [package insert]. Research Triangle Park, NC: ViiV Healthcare; 2015. 9. Triumeq (dolutegravir, abacavir, and lamivudine) [package
From journals.sagepub.com


JULUCA (DOLUTEGRAVIR AND RILPIVIRINE) TABLETS - GSKPRO
Web film-coated tablet contains 50 mg of dolutegravir (equivalent to 52.6 mg dolutegravir sodium) and 25 mg of rilpivirine (equivalent to 27.5 mg rilpivirine hydrochloride). 4 …
From gskpro.com


DOLUTEGRAVIR - USES, DMF, DOSSIER, MANUFACTURER, SUPPLIER, …
Web Dolutegravir// Dolutegravir is indicated for HIV-1 infection for adults and children and adolescents >=12 years of age and weighing >=40 kg. It is marketed as Tivicay as …
From pharmacompass.com


TIVICAY® | VIIV HEALTHCARE CANADA
Web Your own healthcare professional is the best source of information regarding your health. If you need to report an adverse event for any ViiV Healthcare Canada product, please …
From viivhealthcare.com


Related Search